tykhr
sign in
free sign up
Cartesian Therapeutics Inc.
Biotechnology
Healthcare
RNAC
25.90 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
10.02
52 week high
25.14
high
10.23
52 week low
0.00
low
9.68
growth
-38.80 %
previous Close
10.04
P/E ratio
market cap
283 M
div yield
0
usd
Mar 2025
qoq
revenue
1.10 M
244.93 %
net incoming
-17.71 M
-72.73 %
eps
0.00 %
-9.52 %
eps surprise
8.45 %
net profit margin
-1610.00 %
-2960.00 %
operating incoming
-21.89 M
18.11 %
net change in cash
-32.18 M
-388.40 %
cash on hand
180 M
-15.13 %
cost of revenue
0.00 %
top